Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine

10.18632/oncotarget.3234

Saved in:
Bibliographic Details
Main Authors: Kishikawa, T, Otsuka, M, Tan, P.S, Ohno, M, Sun, X, Yoshikawa, T, Shibata, C, Takata, A, Kojima, K, Takehana, K, Ohishi, M, Ota, S, Noyama, T, Kondo, Y, Sato, M, Soga, T, Hoshida, Y, Koike, K
Other Authors: MEDICINE
Format: Article
Published: 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/180954
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-180954
record_format dspace
spelling sg-nus-scholar.10635-1809542024-04-18T03:08:42Z Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine Kishikawa, T Otsuka, M Tan, P.S Ohno, M Sun, X Yoshikawa, T Shibata, C Takata, A Kojima, K Takehana, K Ohishi, M Ota, S Noyama, T Kondo, Y Sato, M Soga, T Hoshida, Y Koike, K MEDICINE amino acid transporter arginine carrier protein ellipticine microRNA 122 nitric oxide nitric oxide synthase pd 407824 protein kinase inhibitor sorafenib unclassified drug arginine carbanilamide derivative microRNA MIRN122 microRNA, human nicotinamide sorafenib animal tissue Article cancer resistance cell level controlled study drug screening drug sensitivity gene silencing human human cell liver cancer cell line liver cell carcinoma mouse nonhuman upregulation analogs and derivatives animal apoptosis biosynthesis C57BL mouse Carcinoma, Hepatocellular deficiency drug resistance genetics Liver Neoplasms metabolism pathology physiology transgenic mouse tumor cell line Animals Apoptosis Arginine Carcinoma, Hepatocellular Cell Line, Tumor Drug Resistance, Neoplasm Humans Liver Neoplasms Mice Mice, Inbred C57BL Mice, Transgenic MicroRNAs Niacinamide Phenylurea Compounds 10.18632/oncotarget.3234 Oncotarget 6 10 8339-8352 2020-10-27T05:51:13Z 2020-10-27T05:51:13Z 2015 Article Kishikawa, T, Otsuka, M, Tan, P.S, Ohno, M, Sun, X, Yoshikawa, T, Shibata, C, Takata, A, Kojima, K, Takehana, K, Ohishi, M, Ota, S, Noyama, T, Kondo, Y, Sato, M, Soga, T, Hoshida, Y, Koike, K (2015). Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine. Oncotarget 6 (10) : 8339-8352. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.3234 19492553 https://scholarbank.nus.edu.sg/handle/10635/180954 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic amino acid transporter
arginine
carrier protein
ellipticine
microRNA 122
nitric oxide
nitric oxide synthase
pd 407824
protein kinase inhibitor
sorafenib
unclassified drug
arginine
carbanilamide derivative
microRNA
MIRN122 microRNA, human
nicotinamide
sorafenib
animal tissue
Article
cancer resistance
cell level
controlled study
drug screening
drug sensitivity
gene silencing
human
human cell
liver cancer cell line
liver cell carcinoma
mouse
nonhuman
upregulation
analogs and derivatives
animal
apoptosis
biosynthesis
C57BL mouse
Carcinoma, Hepatocellular
deficiency
drug resistance
genetics
Liver Neoplasms
metabolism
pathology
physiology
transgenic mouse
tumor cell line
Animals
Apoptosis
Arginine
Carcinoma, Hepatocellular
Cell Line, Tumor
Drug Resistance, Neoplasm
Humans
Liver Neoplasms
Mice
Mice, Inbred C57BL
Mice, Transgenic
MicroRNAs
Niacinamide
Phenylurea Compounds
spellingShingle amino acid transporter
arginine
carrier protein
ellipticine
microRNA 122
nitric oxide
nitric oxide synthase
pd 407824
protein kinase inhibitor
sorafenib
unclassified drug
arginine
carbanilamide derivative
microRNA
MIRN122 microRNA, human
nicotinamide
sorafenib
animal tissue
Article
cancer resistance
cell level
controlled study
drug screening
drug sensitivity
gene silencing
human
human cell
liver cancer cell line
liver cell carcinoma
mouse
nonhuman
upregulation
analogs and derivatives
animal
apoptosis
biosynthesis
C57BL mouse
Carcinoma, Hepatocellular
deficiency
drug resistance
genetics
Liver Neoplasms
metabolism
pathology
physiology
transgenic mouse
tumor cell line
Animals
Apoptosis
Arginine
Carcinoma, Hepatocellular
Cell Line, Tumor
Drug Resistance, Neoplasm
Humans
Liver Neoplasms
Mice
Mice, Inbred C57BL
Mice, Transgenic
MicroRNAs
Niacinamide
Phenylurea Compounds
Kishikawa, T
Otsuka, M
Tan, P.S
Ohno, M
Sun, X
Yoshikawa, T
Shibata, C
Takata, A
Kojima, K
Takehana, K
Ohishi, M
Ota, S
Noyama, T
Kondo, Y
Sato, M
Soga, T
Hoshida, Y
Koike, K
Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine
description 10.18632/oncotarget.3234
author2 MEDICINE
author_facet MEDICINE
Kishikawa, T
Otsuka, M
Tan, P.S
Ohno, M
Sun, X
Yoshikawa, T
Shibata, C
Takata, A
Kojima, K
Takehana, K
Ohishi, M
Ota, S
Noyama, T
Kondo, Y
Sato, M
Soga, T
Hoshida, Y
Koike, K
format Article
author Kishikawa, T
Otsuka, M
Tan, P.S
Ohno, M
Sun, X
Yoshikawa, T
Shibata, C
Takata, A
Kojima, K
Takehana, K
Ohishi, M
Ota, S
Noyama, T
Kondo, Y
Sato, M
Soga, T
Hoshida, Y
Koike, K
author_sort Kishikawa, T
title Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine
title_short Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine
title_full Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine
title_fullStr Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine
title_full_unstemmed Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine
title_sort decreased mir122 in hepatocellular carcinoma leads to chemoresistance with increased arginine
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/180954
_version_ 1800914616437440512